123 days 23 hours 56 mins 37 secs
Join us for a sensational day out on the green for a wonderful cause. Following from the success of our first Golf2Cure Neuroblastoma event in 2018, we will once again be hosting our very own golf event.

Award-Winning Course

The Stonecutters Ridge course was designed by Greg Norman and is considered challenging for players of all levels.

Stonecutters’ 6,257 metre, par 71 course sits among the rolling topography of Eastern Creek in Sydney’s western hills. This world-class 18 hole championship golf course at Stonecutters Ridge has been designed to rank among Australia’s Top 100 Courses.

Are you a Golf2Cure Sponsor?

We have some wonderful ways that your business can support this wonderful event, our charity and your brand. Here is our Sponsorship Pack outlining the many options that you can take advantage of in 2020.

More details to come

We are busy designing a wonderful event for our supporters and will be updating this page with ticketing information, prices, timings and entertainment details soon. If you are interested in attending, please drop Edyta our Events Manager an email to be added to the list.

Raising funds for a world with a cure 

In addition to tickets to the event, we will be organising raffles, silent and live auctions during the day to help raise funds for research into better, kinder treatments for the children's cancer neuroblastoma.  If you or your business would like to provide prizes or sponsor the event, please contact our president Lucy Jones

How your support makes a difference

Take a look at the latest research projects that we have been able to fund thanks to supporters just like you.
Thank you for your support.
Donate today Help us beat the number one toddler cancer. Currently, only 50% of those children diagnosed with aggressive neuroblastoma will survive five years after diagnosis – and a third of those children that do survive, will have long term side effects from their treatments. Please donate today to support world class Australian research into developing better, safer treatments. Find out more